Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily
See the Price Targets and Ratings of:
RMD Analyst Ratings
Moderate Buy
6 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RMD Stock 12 Month Forecast
Average Price Target
$247.14
▲(5.28% Upside)
| Highest Price Target$283.00 | Average Price Target$247.14 | Lowest Price Target$180.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Assigned
11/08/24
Jefferies
Reiterated
10/25/24
Oppenheimer
Reiterated
10/25/24
J.P. Morgan
Reiterated
10/25/24
KeyBanc
Reiterated
10/25/24
Robert W. Baird
Assigned
10/25/24
RBC Capital
Reiterated
10/25/24
Needham
Reiterated
10/25/24
Mizuho Securities
Assigned
10/08/24
Wolfe Research
Downgraded
09/17/24
William Blair
―
Buy
―
Reiterated
08/27/24
ResMed sees 'tidal wave' from weight loss drugs, says William BlairResMed sees 'tidal wave' from weight loss drugs, says William Blair
UBS
$210→$225
Hold
-4.15%
Downside
Reiterated
08/05/24
ResMed (RMD) PT Raised to $225 at UBSUBS analyst Laura Sutcliffe raised the price target on ResMed (NYSE: RMD) to $225.00 (from $210.00) while maintaining a Neutral rating.
Citi
―
Buy
―
Reiterated
06/24/24
Australian Stocks: ResMed Shares Tumble on Rivals Weight-Loss Drug Results - TipRanks.comDespite investors concerns over ResMeds future sales, analysts remain positive. After the shares dipped today, analyst Mathieu Chevrier from Citi reiterated a Buy rating on RMD stock, predicting an upside of 28.5%.
Best Analysts Covering Resmed
Which Analyst Should I Follow If I Want to Buy RMD and Sell After:
1 Month
xxx
Success Rate
11/17 ratings generated profit
Average Return
+3.53%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +3.53% per trade.
3 Months
xxx
Success Rate
14/19 ratings generated profit
Average Return
+6.65%
assigned a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +6.65% per trade.
1 Year
Success Rate
14/19 ratings generated profit
Average Return
+16.04%
assigned a buy rating 15 days ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 73.68% of your transactions generating a profit, with an average return of +16.04% per trade.
2 Years
xxx
Success Rate
17/19 ratings generated profit
Average Return
+22.61%
assigned a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 89.47% of your transactions generating a profit, with an average return of +22.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RMD Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
13
11
11
19
14
Hold
4
6
7
13
9
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
17
17
19
33
24
Each month's total comprises the sum of three months' worth of ratings.
RMD Financial Forecast
RMD Stock Forecast FAQ
What is RMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Resmed’s 12-month average price target is $247.14.
What is RMD’s upside potential, based on the analysts’ average price target?
Resmed has 5.28% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RMD a Buy, Sell or Hold?
Resmed has a consensus rating of Moderate Buy which is based on 6 buy ratings, 4 hold ratings and 1 sell ratings.
What is Resmed’s price target?
The average price target for Resmed is $247.14. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $283.00 ,the lowest forecast is $180.00. The average price target represents 5.28% Increase from the current price of $234.74.
The highest analyst price target is $283.00 ,the lowest forecast is $180.00. The average price target represents 5.28% Increase from the current price of $234.74.
What do analysts say about Resmed?
Resmed’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of RMD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.